Skip to content
Stock screener

CI Cigna Group stock chart & analysis

Conviction 27HealthcareScan · Fri, Nov 6, 2026
Three outside down

Cigna Group (CI) closed at $293.59 (-2.62%) on Nov 6, 2026. Its latest daily candle is a three outside down. Price is above its 50-day and above its 200-day moving average. RSI(14) 50, RS Rating 79, -7.7% from its 52-week high, +6.7% year to date. Sector: Healthcare · Hospital & Medical Service Plans.

CI$293.59-2.62%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Cigna GroupHospital & Medical Service Planswww.thecignagroup.com ↗
Price293.59
Change-2.62%
Gap-2.26%
Rel volume1.37×
Avg volume1.64M
Avg $ vol492.38M
SMA 20298.78
SMA 50285.81
SMA 200282.22
Price vs 50+2.73%
Price vs 200+4.04%
MA stackbullish
50/200 cross—
Supertrendup · 287.83
RSI (14)50
MACD hist-1.17
MACD crossbear · 6d
Stoch %K / %D6 / 33
ADX (14)24
+DI / −DI32 / 20
RSI divergence—
MACD divergence—
ATR %2.85%
ADR %2.53%
52w high318.05
52w low255.53
From 52w high-7.68%
Above 52w low+14.91%
New 52w highNo
SqueezeOff
Bollinger width10.44%
%B0.33
Donchian pos39.84%
Donchian high318.05
Donchian low277.43
AVWAP (52w high)301.08
vs AVWAP high-2.48%
AVWAP (52w low)279.85
vs AVWAP low+4.92%
OBV trendFlat
Chaikin MF (20)-0.07
Today vs 20d1.37×
Avg vol (14d)1.72M
Avg vol (20d)1.64M
Avg $ vol (20d)492.38M
Market cap77.37B
RS Rating79 / 99
RS 3m (vs SPY)+10.33%
RS 6m (vs SPY)+2.23%
RS line new highNo
Trend template7/8
Technical rank75.9
1 week-1.55%
1 month+4.48%
3 months+5.47%
6 months+1.93%
1 year+13.11%
YTD+6.68%
P/E12.99
P/B1.78
P/S0.28
P/FCF9.05
EPS22.18
Div yield2.08%
ROE13.73%
ROA3.78%
Debt/Eq0.96
Current0.84
EV/EBITDA9.44
Gross margin21.79%
Net margin2.17%
Rev growth11.24%
EPS growth73.47%
Price target341.43
Target upside16.28%
Analyst ratingBuy
Institutional100.87%
Ent. value113B
Revenue73.68B
Net income1.44B
Gross profit15.09B
Free cash flow8.55B
IndustryHospital & Medical Service Plans
ExchangeNYSE
Shares out264.53M
Employees67.7K
ListedThu, Apr 1, 1982
Free float261.84M
Float %99.4%
Short interest—
Days to cover—
Short volume52.2%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$7.98 vs $7.46
Last surprise+7.0% beat
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank75.9 / 100
Group rank23 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside down

Financials as of Wed, Sep 30, 2026 · quarterly.

CI technical analysis

Trend

CI is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 2.7% above the 50-day ($285.81) and 4.0% above the 200-day ($282.22). ADX(14) at 24 points to a moderate trend. It meets 7 of 8 trend-template criteria.

Momentum

RSI(14) is 50, in the bearish half of its range. MACD crossed below its signal line 6 sessions ago. Its RS Rating of 79 puts its weighted 12-month performance ahead of about 79% of the US market.

Volume and volatility

Volume on the latest session ran 1.4× its 20-day average. It trades about $492.4M a day on average. ATR(14) is $8.37, 2.9% of price — its typical daily range. Chaikin Money Flow (-0.07) shows distribution.

Key levels

The 52-week range is $255.53 to $318.05; price is 7.7% below the high and 14.9% above the low. The VWAP anchored at the 52-week high is $301.08, above price.

Performance

CI returned -1.6% (1 week), +4.5% (1 month), +5.5% (3 months), +1.9% (6 months), +13.1% (1 year), +6.7% (year to date).

About Cigna Group

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.

Hospital & Medical Service Plans · Listed 1982 · 67,700 employees

Congress activity

Disclosed STOCK Act trades in CI · 10 recent

All disclosures →
MemberSideAmount
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-09-23
Buy$1K–$15K
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-03-13
Sell$1K–$15K
Jared Moskowitz
Jared Moskowitz
house · FL · traded 2026-03-23
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2025-09-23
Sell$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-09-25
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2024-10-29
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-08-05
Sell$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-08-14
Sell$1K–$15K
Julia Letlow
Julia Letlow
house · LA · traded 2025-04-22
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in CI · open-market 1 sell

InsiderSideShares
Kurian George
Director · Phantom Stock Units · 2026-08-31
Grant108.664
Jones Nicole S
See Remarks · Common Stock, $.01 Par Value · 2026-08-18
Sell2.68K
Holgerson Bryan
See Remarks · Phantom Stock Units · 2026-08-06
Grant0.984
Holgerson Bryan
See Remarks · Phantom Stock Units · 2026-07-23
Grant0.946
Holgerson Bryan
See Remarks · Phantom Stock Units · 2026-07-09
Grant0.887
Koka Durga Prasad
EVP, Global CIO · Common Stock, $.01 Par Value · 2026-06-01
Tax729
Kurian George
Director · Phantom Stock Units · 2026-05-29
Grant108.147
Cordani David
Chairman & CEO · Common Stock, $.01 Par Value · 2026-05-13
Exercise15.46K
Cordani David
Chairman & CEO · Employee Stock Option (Right to Buy) · 2026-05-13
Exercise15.46K
Cordani David
Chairman & CEO · Common Stock, $.01 Par Value · 2026-05-13
Exercise7.97K

SEC filings

EDGAR filings in CI · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.